rs2228117
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000397.4(CYBB):c.1002G>A(p.Lys334=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00969 in 1,209,331 control chromosomes in the GnomAD database, including 698 homozygotes. There are 3,144 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.052 ( 374 hom., 1570 hem., cov: 22)
Exomes 𝑓: 0.0054 ( 324 hom. 1574 hem. )
Consequence
CYBB
NM_000397.4 synonymous
NM_000397.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.153
Genes affected
CYBB (HGNC:2578): (cytochrome b-245 beta chain) Cytochrome b (-245) is composed of cytochrome b alpha (CYBA) and beta (CYBB) chain. It has been proposed as a primary component of the microbicidal oxidase system of phagocytes. CYBB deficiency is one of five described biochemical defects associated with chronic granulomatous disease (CGD). In this disorder, there is decreased activity of phagocyte NADPH oxidase; neutrophils are able to phagocytize bacteria but cannot kill them in the phagocytic vacuoles. The cause of the killing defect is an inability to increase the cell's respiration and consequent failure to deliver activated oxygen into the phagocytic vacuole. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant X-37803981-G-A is Benign according to our data. Variant chrX-37803981-G-A is described in ClinVar as [Benign]. Clinvar id is 464971.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-37803981-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.153 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.172 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYBB | NM_000397.4 | c.1002G>A | p.Lys334= | synonymous_variant | 9/13 | ENST00000378588.5 | |
CYBB | XM_047441855.1 | c.696G>A | p.Lys232= | synonymous_variant | 8/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYBB | ENST00000378588.5 | c.1002G>A | p.Lys334= | synonymous_variant | 9/13 | 1 | NM_000397.4 | P1 | |
CYBB | ENST00000696171.1 | c.906G>A | p.Lys302= | synonymous_variant | 8/12 | ||||
CYBB | ENST00000492288.1 | n.427G>A | non_coding_transcript_exon_variant | 4/4 | 3 | ||||
CYBB | ENST00000696170.1 | c.*511G>A | 3_prime_UTR_variant, NMD_transcript_variant | 8/12 |
Frequencies
GnomAD3 genomes AF: 0.0518 AC: 5771AN: 111434Hom.: 373 Cov.: 22 AF XY: 0.0465 AC XY: 1564AN XY: 33668
GnomAD3 genomes
AF:
AC:
5771
AN:
111434
Hom.:
Cov.:
22
AF XY:
AC XY:
1564
AN XY:
33668
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0153 AC: 2795AN: 183062Hom.: 174 AF XY: 0.0102 AC XY: 691AN XY: 67652
GnomAD3 exomes
AF:
AC:
2795
AN:
183062
Hom.:
AF XY:
AC XY:
691
AN XY:
67652
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00542 AC: 5945AN: 1097846Hom.: 324 Cov.: 31 AF XY: 0.00433 AC XY: 1574AN XY: 363404
GnomAD4 exome
AF:
AC:
5945
AN:
1097846
Hom.:
Cov.:
31
AF XY:
AC XY:
1574
AN XY:
363404
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0518 AC: 5779AN: 111485Hom.: 374 Cov.: 22 AF XY: 0.0465 AC XY: 1570AN XY: 33729
GnomAD4 genome
AF:
AC:
5779
AN:
111485
Hom.:
Cov.:
22
AF XY:
AC XY:
1570
AN XY:
33729
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Granulomatous disease, chronic, X-linked Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Chronic granulomatous disease Benign:1
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at